In a patient aged 65 years or older with osteoporosis, one year after revision intramedullary nailing of an intertrochanteric femur fracture, what follow‑up evaluation, imaging, weight‑bearing recommendations, rehabilitation, bone‑health optimization, and fall‑prevention strategies are advised?

One-Year Post-Revision Intramedullary Nailing Follow-Up Protocol

At one year post-revision intramedullary nailing of an intertrochanteric femur fracture in an osteoporotic patient ≥65 years, continue full weight-bearing as tolerated, obtain standing AP pelvis and lateral hip radiographs to assess union and hardware position, ensure ongoing osteoporosis pharmacotherapy with bisphosphonates, maintain calcium 1000-1200 mg/day plus vitamin D 800 IU/day, and implement multidimensional fall prevention with balance training. 1, 2, 3

Imaging and Clinical Evaluation

• Obtain standing radiographs (AP pelvis and lateral hip) to assess fracture union, hardware position, and any signs of implant failure or loosening 3, 4
• Evaluate for screw cut-out, Z-effect, or reverse Z-effect, which are common technical failures in osteoporotic bone, particularly in patients with severe osteoporosis (Singh index grades I-II) 5
• Assess gait pattern and weight-bearing tolerance during clinical examination, as pain with weight-bearing suggests hardware failure or nonunion even at one year 6
• If persistent pain is present, consider advanced imaging (MRI or CT) to evaluate for occult nonunion or hardware complications 1

Weight-Bearing and Mobilization

• Continue full weight-bearing as tolerated without restrictions, as immediate and continued weight-bearing improves outcomes and reduces complications 1, 3
• Early and sustained mobilization protocols are essential for maintaining functional independence and reducing morbidity 3
• Patients with stability scores ≥5 on postoperative radiographs have predictable maintenance of reduction and can safely continue unrestricted weight-bearing 4

Bone Health Optimization

Pharmacological Treatment

• Ensure ongoing bisphosphonate therapy (alendronate or risedronate as first-line agents) if initiated post-fracture, as these reduce vertebral, non-vertebral, and hip fracture risk 2, 7
• For patients not yet on pharmacotherapy, initiate bisphosphonates immediately given the fragility fracture history 2, 6
• Zoledronic acid 5 mg IV annually is an alternative for patients with oral intolerance, malabsorption, dementia, or non-compliance, and has demonstrated efficacy in promoting fracture healing and preventing new fractures 2, 8
• Denosumab (subcutaneous) is another alternative for patients unable to tolerate oral bisphosphonates 2
• Continue treatment for 3-5 years minimum, and longer in patients who remain at high risk 2

Non-Pharmacological Treatment

• Maintain calcium intake of 1000-1200 mg/day (diet plus supplementation if needed) combined with vitamin D 800 IU/day 2, 6
• High pulse doses of vitamin D should be avoided as they increase fall risk 2
• Smoking cessation and alcohol limitation are essential, as unhealthy lifestyle negatively affects bone mineral density, bone quality, and fall risk 2

Monitoring

• Order DEXA scan if not performed within the past year to assess bone mineral density response to treatment 3, 6
• Systematic follow-up through a Fracture Liaison Service (FLS) is the most effective organizational structure for ensuring adherence to osteoporosis treatment and preventing subsequent fractures 3, 6
• Monitor adherence to pharmacotherapy, as long-term adherence is typically poor without systematic follow-up 2

Fall Prevention and Rehabilitation

• Implement multidimensional fall prevention strategies including balance training, which should be continued long-term 2
• Physical training and muscle strengthening should have been initiated early post-fracture and continued throughout the first year 2
• The primary goal is maintaining the level of mobility and independence enjoyed before the fracture occurred 2
• Balance training combined with adequate vitamin D supplementation (800 IU/day) reduces falls by 15-20% 2

Pain Management at One Year

• If persistent pain is present, initiate physical therapy focusing on hip abductor strengthening 6
• Use regular acetaminophen as first-line analgesia 6
• Avoid NSAIDs due to acute kidney injury and gastrointestinal complications in elderly patients 6
• Use opioids cautiously only if necessary, as elderly patients are vulnerable to accumulation, over-sedation, and respiratory depression 6
• Never use codeine due to constipation, emesis, and association with postoperative cognitive dysfunction 6

Common Pitfalls

• Failure to maintain osteoporosis treatment beyond the immediate post-fracture period leads to subsequent fractures; 2 new hip fractures and 2 distal radius fractures occurred in control patients not receiving zoledronic acid versus zero new fractures in treated patients over 12 months 8
• Inadequate calcium and vitamin D supplementation undermines pharmacological osteoporosis treatment effectiveness 2
• Neglecting fall prevention after fracture healing misses the opportunity to prevent the next fracture 2
• Osteoporosis severity (Singh index grades I-II) significantly worsens clinical outcomes (mean Harris hip score) even with successful fixation, emphasizing the critical importance of aggressive bone health optimization 5